Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study

Open access
Li, Ning, Chen, Hongyan, Cheng, Yi, Xu, Fenghua, Ruan, Guangcong, Ying, Senhong, Tang, Wen, Chen, Lu, Chen, Minjia, Lv, LinLing, Ping, Yi, Chen, Dongfeng, Wei, Yanling · 2021 · Frontiers in Cellular and Infection Microbiology

Abstract

Autism spectrum disorder (ASD) is a severe brain development disorder that is characterized by deficits in social communication and restricted, repetitive and stereotyped behaviors. Accumulating evidence has suggested that gut microbiota disorders play important roles in gastrointestinal symptoms and neurodevelopmental dysfunction in ASD patients. Manipulation of the gut microbiota by fecal microbiota transplantation (FMT) was recently shown to be a promising therapy for the treatment of various diseases. Here, we performed a clinical trial to evaluate the effect of FMT on gastrointestinal (GI) and ASD symptoms and gut microbiota alterations in children with ASD. We found that there was a large difference in baseline characteristics of behavior, GI symptoms, and gut microbiota between children with ASD and typically developing (TD) control children. FMT could improve GI symptoms and ASD symptoms without inducing any severe complications. Similarly, FMT significantly changed the serum levels of neurotransmitters. We further observed that FMT could promote the colonization of donor microbes and shift the bacterial community of children with ASD toward that of TD controls. The abundance of Eubacterium coprostanoligenes pre-FMT was positively correlated with high GSRS scores, whereas a decrease in Eubacterium coprostanoligenes abundance induced by FMT was associated with the FMT response. Our data suggest that FMT might be a promising therapeutic strategy to improve the GI and behavioral symptoms of patients with ASD, possibly due to its ability to alter gut microbiota and highlight a specific microbiota intervention that targets Eubacterium coprostanoligenes that can enhance the FMT response. This trial was registered at the Chinese Clinical Trial Registry (www.chictr.org.cn) (trial registration number ChiCTR1800014745).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcimb.2021.759435

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 21

  1. Bajaj, 2017, Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial, Hepatology, 66, 1727, 10.1002/hep.29306 · DOI · Paper page
  2. Bermudez-Martin, 2021, The Microbial Metabolite P-Cresol Induces Autistic-Like Behaviors in Mice by Remodeling the Gut Microbiota, Microbiome, 9, 157, 10.1186/s40168-021-01103-z · DOI · Paper page
  3. Bhandari, 2020, Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors, Adv. Neurobiol., 24, 97, 10.1007/978-3-030-30402-7_4 · DOI
  4. Davies, 2021, Altering the Gut Microbiome to Potentially Modulate Behavioral Manifestations in Autism Spectrum Disorders: A Systematic Review, Neurosci. Biobehav. Rev., 128, 549, 10.1016/j.neubiorev.2021.07.001 · DOI
  5. Ericsson, 2017, Variable Colonization After Reciprocal Fecal Microbiota Transfer Between Mice With Low and High Richness Microbiota, Front. Microbiol., 8, 10.3389/fmicb.2017.00196 · DOI
  6. Famitafreshi, 2018, Overview of the Recent Advances in Pathophysiology and Treatment for Autism, CNS Neurol. Disord. Drug Targets, 17, 590, 10.2174/1871527317666180706141654 · DOI
  7. Fung, 2017, Interactions Between the Microbiota, Immune and Nervous Systems in Health and Disease, Nat. Neurosci., 20, 145, 10.1038/nn.4476 · DOI · Paper page
  8. Han, 2021, Maternal Immune Activation and Neuroinflammation in Human Neurodevelopmental Disorders, Nat. Rev. Neurol., 17, 564, 10.1038/s41582-021-00530-8 · DOI · Paper page
  9. Ianiro, 2018, Randomised Clinical Trial: Faecal Microbiota Transplantation by Colonoscopy Plus Vancomycin for the Treatment of Severe Refractory Clostridium Difficile Infection-Single Versus Multiple Infusions, Aliment. Pharmacol. Ther., 48, 152, 10.1111/apt.14816 · DOI · Paper page
  10. Kang, 2017, Microbiota Transfer Therapy Alters Gut Ecosystem and Improves Gastrointestinal and Autism Symptoms: An Open-Label Study, Microbiome, 5, 10, 10.1186/s40168-016-0225-7 · DOI · Paper page
  11. Kelly, 2016, Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium Difficile Infection: A Randomized Trial, Ann. Intern. Med., 165, 609, 10.7326/M16-0271 · DOI · Paper page
  12. Kushak, 2016, Evaluation of Intestinal Function in Children With Autism and Gastrointestinal Symptoms, J. Pediatr. Gastroenterol. Nutr., 62, 687, 10.1097/MPG.0000000000001174 · DOI
  13. Li, 2017, The Gut Microbiota and Autism Spectrum Disorders, Front. Cell Neurosci., 11, 10.3389/fncel.2017.00120 · DOI · Paper page
  14. Madra, 2020, Gastrointestinal Issues and Autism Spectrum Disorder, Child Adolesc. Psychiatr. Clin. N. Am., 29, 501, 10.1016/j.chc.2020.02.005 · DOI · Paper page
  15. Naveed, 2021, Gut-Brain Axis: A Matter of Concern in Neuropsychiatric Disorders...!, Prog. Neuropsychopharmacol. Biol. Psychiatry, 104, 10.1016/j.pnpbp.2020.110051 · DOI
  16. Patusco, 2018, Role of Probiotics in Managing Gastrointestinal Dysfunction in Children With Autism Spectrum Disorder: An Update for Practitioners, Adv. Nutr., 9, 637, 10.1093/advances/nmy031 · DOI
  17. Vargason, 2019, Gastrointestinal Symptoms and Oral Antibiotic Use in Children With Autism Spectrum Disorder: Retrospective Analysis of a Privately Insured U.S. Population, J. Autism Dev. Disord., 49, 647, 10.1007/s10803-018-3743-2 · DOI
  18. Vuong, 2017, Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder, Biol. Psychiatry, 81, 411, 10.1016/j.biopsych.2016.08.024 · DOI · Paper page
  19. Wan, 2013, Prevalence of Autism Spectrum Disorders Among Children in China: A Systematic Review, Shanghai Arch. Psychiatry, 25, 70, 10.3969/j.issn.1002-0829.2013.02.003 · DOI
  20. Xu, 2021, Clinical Efficacy of Fecal Microbiota Transplantation for Patients With Small Intestinal Bacterial Overgrowth: A Randomized, Placebo-Controlled Clinic Study, BMC Gastroenterol., 21, 54, 10.1186/s12876-021-01630-x · DOI
  21. Zuo, 2018, Gut Fungal Dysbiosis Correlates With Reduced Efficacy of Fecal Microbiota Transplantation in Clostridium Difficile Infection, Nat. Commun., 9, 3663, 10.1038/s41467-018-06103-6 · DOI · Paper page

Cited by

See all 188

Metadata

Authors
Li, N., Chen, H., Cheng, Y., Xu, F., Ruan, G., Ying, S., Tang, W., Chen, L., Chen, M., Lv, L., Ping, Y., Chen, D., & Wei, Y.
Venue
Frontiers in Cellular and Infection Microbiology
Published
2021-10-19
Volume
11
Pages
759435-759435
ISSN
2235-2988 (ISSN-L)
OpenAlex
W3206211002
Cited by
188
References
14
FWCI
7.45
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study. https://app.cochat.ai/papers/10.3389/fcimb.2021.759435
The paper
Li, N., Chen, H., Cheng, Y., Xu, F., Ruan, G., Ying, S., Tang, W., Chen, L., Chen, M., Lv, L., Ping, Y., Chen, D., & Wei, Y. (2021). Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2021.759435

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.